Anavex Life Sciences Corp. Profile Avatar - Palmy Investing

Anavex Life Sciences Corp.

Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial…

Biotechnology
US, New York [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Anavex Life Sciences Corp. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Anavex Life Sciences Corp. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Anavex Life Sciences Corp..

End of AVXL's Analysis
CIK: 1314052 CUSIP: 032797300 ISIN: US0327973006 LEI: - UEI: -
Secondary Listings
AVXL has no secondary listings inside our databases.